Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
3 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jun 29, 2026 through Aug 20, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
Dermatologists and skin experts are providing guidance on the best sunscreens and application methods to prevent skin cancer and aging.
Researchers have identified a tiny Antarctic sea creature that may be instrumental in developing new treatments for melanoma.